Date:June 15, 2026

Kigali, Rwanda — Bio Usawa Biotechnology is pleased to welcome its CEO and President to Kigali as part of the company’s ongoing scientific and operational activities in the region.
Dr. Menghis Bairu is personally on site to observe the offloading process, reflecting Bio Usawa Biotechnology’s hands-on leadership approach and strong commitment to quality, safety, and operational excellence.

Bio Usawa Biotechnology is driven by a mission to advance science-based biotechnology solutions that improve health outcomes and strengthen local and regional capacity.
Through innovation, rigorous scientific standards, and strategic partnerships, the company works to translate advanced biotechnology into sustainable, real-world impact—particularly in emerging and underserved markets.

The visit highlights Bio Usawa Biotechnology’s long-term vision of combining cutting-edge science with responsible implementation to support resilient health systems and expand global access to essential biotechnological solutions.
Great to connect with Dr. Delese Mimi Darko, Director General of the African Medicines Agency (AMA), and Senior Advisor Prof. Alex Dodoo this week. W…
June 2026At the Grand Challenges Annual Meeting 2026 in London, a clear and urgent theme emerged: Africa’s future in biotechnology will be defined not by a short…
June 2026Prof. Nazik Hammad, Bio Usawa’s Chief Medical Officer for Oncology, recently visited the company’s emerging manufacturing facility in the Kigali Special…
June 2026